The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $8.89

Today's change-0.24 -2.58%
Updated February 23 2:12 PM EST. Delayed by at least 15 minutes.
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $8.89

Today's change-0.24 -2.58%
Updated February 23 2:12 PM EST. Delayed by at least 15 minutes.

Sharp drop following new 50-day high

Community Health Systems Inc is sharply lower today, dropping (U.S.)$0.24 or 2.58% to (U.S.)$8.89 after setting a new 50-day high. Over the last five days, shares have gained 24.79% and 58.94% year to date. Shares have underperformed the S&P 500 by 62.31% during the last year.

Key company metrics

  • Open(U.S.) $9.18
  • Previous close(U.S.) $9.12
  • High(U.S.) $9.34
  • Low(U.S.) $8.76
  • Bid / Ask(U.S.) $8.88 / (U.S.) $8.89
  • YTD % change+58.94%
  • Volume5,700,433
  • Average volume (10-day)5,692,586
  • Average volume (1-month)4,004,065
  • Average volume (3-month)5,109,525
  • 52-week range(U.S.) $4.15 to (U.S.) $21.38
  • Beta1.61
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward14.44×
  • Forward PEG62.77×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$15.39
Updated February 23 2:12 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-8.74%

Although this company's net profit margin is negative, it is above the industry average and implies that Community Health Systems Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.12%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue4,3804,5904,9994,798
Total other revenue--------
Total revenue4,3804,5904,9994,798
Gross profit3,6573,8314,2004,024
Total cost of revenue723759799774
Total operating expense4,2345,9954,7054,651
Selling / general / administrative2,1762,2662,4362,405
Research & development--------
Depreciation / amortization265276298297
Interest expense (income), net operating--------
Unusual expense (income)491,6691765
Other operating expenses, total1,0211,0251,1551,110
Operating income146-1,405294147
Interest income (expense), net non-operating-233-246-251-265
Gain (loss) on sale of assets--------
Other--------
Income before tax-83-1,54363-91
Income after tax-54-1,40537-40
Income tax, total-29-13826-51
Net income-79-1,43211-83
Total adjustments to net income--------
Net income before extra. items-77-1,43112-74
Minority interest-23-26-25-34
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-77-1,43112-74
Inc. avail. to common incl. extra. items-79-1,43211-83
Diluted net income-79-1,43211-83
Dilution adjustment0--00
Diluted weighted average shares111111110113
Diluted EPS excluding extraordinary itemsvalue per share-0.69-12.910.11-0.66
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.41-3.120.20-0.28